The Important Role of Lipoprotein(a) in Cardiovascular Disease: Present and Future Therapeutic Options

Quiz-summary

0 of 7 questions completed

Questions:

[Quiz Loading]

You have already completed the quiz before. Hence you can not start it again.

Quiz is loading...

You must sign in or sign up to start the quiz.

You have to finish following quiz, to start this quiz:

Results

CE Course

Question 1 of 7

1. Question
Pre-Activity
Currently, how confident are you in your ability to: 1 = not confident, 2 = somewhat confident, 3 = confident, 4 = very confident, 5 = extremely confident, N/A = not applicable to me
- Develop personalized treatment plans for patients with cardiovascular disease 1 2 3 4 5 N/A Apply newer scientific advances and therapeutic approaches involving lipoprotein(a) to patients for the treatment of cardiovascular disease 1 2 3 4 5 N/A
Question 2 of 7

2. Question
Indicate how often you CURRENTLY use each of the following clinical practice strategies for your patients with cardiovascular disease. *1 = Never, 2 = Not often, 3 = Sometimes, 4 = Often, 5 = Always, N/A = Not applicable to me
- Analyze the science of Lp(a) and its role in the management and prevention of cardiovascular risk 1 2 3 4 5 N/A Implement clinical trial data and mechanisms of action of emerging therapeutics to reduce Lp(a) 1 2 3 4 5 N/A Incorporate new and emerging scientific data into individualized treatment strategies to optimally manage Lp(a) and improve cardiovascular outcomes 1 2 3 4 5 N/A
Question 3 of 7

3. Question
1. High lipoprotein(a) is causally related to the increased risk of:
- Aortic stenosis
- Myocardial infarction
- Familial hypercholesterolemia
- All of the above
Question 4 of 7

4. Question
2. Which of the following is true?
- Apolipoprotein(a) kringle number determines Lp(a) isoform size
- Proinflammatory oxidized phospholipids can be carried by apo(a)
- Apolipoprotein(a) closely resembles fibrinogen
- Both a and b
- All of the above
Question 5 of 7

5. Question
3. Regarding Lp(a), which of the following answer choice is correct?
- High Lp(a) is a rare genetic dyslipidemia
- High Lp(a) is associated with a very small increase in risk of ASCVD
- High Lp(a) has been linked with premature MI, childhood stroke and progression of aortic stenosis
- Screening for Lp(a) should not be performed since it does not change management
- Lowering Lp(a) to normal levels would be expected to reduce 1 in 100 MIs in the population
Question 6 of 7

6. Question
4. Which of the following answer choices is true regarding treatment for elevated Lp(a) levels?
- Statin therapy lowers Lp(a) levels by 30% and decreases oxidized phospholipids by a similar amount
- Niacin lowers Lp(a) levels and CVD events by at least 30%
- The reduction of Lp(a) with PCSK9 inhibitors is strongly correlated with the magnitude of LDL-C lowering
- Lipid-apheresis improves symptoms in patients with refractory angina and an elevated Lp(a)
- High fat and low vegetable diets increase Lp(a) levels
Question 7 of 7

7. Question
5. Based on current knowledge, the most effective method to reduce plasma levels of Lp(a) is:
- Inhibit apoB synthesis
- Inhibit apo(a) synthesis
- Inhibit plasminogen synthesis
- Upregulate LDL receptor expression

The Important Role of Lipoprotein(a) in Cardiovascular Disease: Present and Future Therapeutic Options

Quiz-summary

Information

Results

Categories

CE Course

1. Question

Pre-Activity

2. Question

3. Question

4. Question

5. Question

6. Question

7. Question

CONTACT

RESOURCES

ACCOUNT